BU-NOT-SET

CONTACT US
Stability studies are ever changing: Outsourcing as a viable option
  • Analytical chemistry
Development workers
Insight
Navigating the regulatory landscape for controlled substances
  • Drug substance
Man at work
Insight
How to speed up vaccine development and production
  • Manufacturing
Vaccine
eBook
Reducing time to market with analytical chemistry
  • Analytical chemistry
Workers
Insight
Serialisation – Looking for value-added opportunities
  • Manufacturing
Eyes
Insight
Outlining the key steps to analytical method development
  • Analytical chemistry
Eyes
Insight
Outsourcing formulation development & manufacturing
  • Drug product
Eyes
Insight
Complying with Annex 1: Things to bear in mind
  • Drug product
Eyes
Insight
Optimising a prolonged release fixed dose combination product
  • Drug product
pills
Case study
Insight
  • Analytical chemistry
The QbD approach: Key advantages in clinical and commercial phases
Report
  • Sustainability
Sustainability report 2020
Poster
  • Drug substance
Recipharm and Oncopeptides: Successful collaboration in the development of melflufen, a peptidase-potentiated alkylating agent in clinical trials
Fact sheet
  • Analytical chemistry
Recipharm Analytical Solutions™
Fact sheet
  • Analytical chemistry
Impurity identification
Fact sheet
  • Analytical chemistry
Stability studies
Fact sheet
  • Analytical chemistry
Extractables & leachables testing
Insight
  • Industry trends
Pharmaceutical mergers and acquisitions: opportunities and drivers for CDMOs
Insight
  • Industry trends
Global expansion in the CDMO field